Abstract
Individual cancer cells in a tumor are very diverse both genetically and functionally. Moreover, in many cancers, whether a tumor flourishes or dies after a given treatment depends on a small fraction of cells in the tumor, for instance, the cancer stem cells, rather than the bulk population. Traditionally, scientists only obtain averaged information from the entire population of cells in a bulk tumor, but it is critical to develop an effective and user-friendly platform capable of interrogating single cells in order to understand and treat the disease better. This chapter reviews recent progress of microfluidics-based tools for single cell analysis that are relevant for cancer characterization, as well as how nanotechnology may advance the analysis with improved signal responses. We hope that this general introduction may catalyze the adoption of these advanced single-cell analysis approaches for cancer studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bertucci F, Birnbaum D (2008) Reasons for breast cancer heterogeneity. J Biol 7:6
Brouzes E et al (2009) Droplet microfluidic technology for single-cell high-throughput screening. Proc Natl Acad Sci U S A 106:14195–14200
Cai L, Friedman N, Xie XS (2006) Stochastic protein expression in individual cells at the single molecule level. Nature 440:358–362
Levsky JM, Shenoy SM, Pezo RC, Singer RH (2002) Single-cell gene expression profiling. Science 297:836–840
Raj A, Peskin CS, Tranchina D, Vargas DY, Tyagi S (2006) Stochastic mRNA synthesis in mammalian cells. PLoS Biol 4:e309
Chang HH, Hemberg M, Barahona M, Ingber DE, Huang S (2008) Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 453:544–547
Nwosu V, Carpten J, Trent JM, Sheridan R (2001) Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease. Hum Mol Genet 10:2313–2318
Shackleton M, Quintana E, Fearon ER, Morrison SJ (2009) Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138:822–829
Williams JL (2012) Cancer stem cells. Clin Lab Sci 25:50–57
Merlos-Suárez A et al (2011) The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8:511–524
Kumar-Sinha C, Tomlins SA, Chinnaiyan AM (2008) Recurrent gene fusions in prostate cancer. Nat Rev Cancer 8:497–511
Mackinnon AC, Yan BC, Joseph LJ, Al-Ahmadie HA (2009) Molecular biology underlying the clinical heterogeneity of prostate cancer: an update. Arch Pathol Lab Med 133:1033–1040
Devi GR (2006) siRNA-based approaches in cancer therapy. Cancer Gene Ther 13:819–829
Spiller DG, Wood CD, Rand DA, White MRH (2010) Measurement of single-cell dynamics. Nature 465:736–745
Alix-Panabières C, Schwarzenbach H, Pantel K (2012) Circulating tumor cells and circulating tumor DNA. Annu Rev Med 63:199–215
Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4:448–456
Yu M, Stott S, Toner M, Maheswaran S, Haber DA (2011) Circulating tumor cells: approaches to isolation and characterization. J Cell Biol 192:373–382
Pantel K, Alix-Panabières C, Riethdorf S (2009) Cancer micrometastases. Nat Rev Clin Oncol 6:339–351
Rolle A et al (2005) Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC(R) is a predictor for relapse: a preliminary report. World J Surg Oncol 3:18
Krivacic RT et al (2004) A rare-cell detector for cancer. Proc Natl Acad Sci U S A 101:10501–10504
Bednarz-Knoll N, Alix-Panabières C, Pantel K (2011) Clinical relevance and biology of circulating tumor cells. Breast Cancer Res 13:228
Pinzani P et al (2006) Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. Hum Pathol 37:711–718
Hofman VJ et al (2011) Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls. Am J Clin Pathol 135:146–156
Vona G et al (2000) Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol 156:57–63
Deng G et al (2008) Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients. Breast Cancer Res 10:R69
Nagrath S et al (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450:1235–1239
Saliba A-E et al (2010) Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays. Proc Natl Acad Sci U S A 107:14524–14529
Went P, Lugli A, Meier S, Bundi M (2004) Frequent EpCam protein expression in human carcinomas. Hum Pathol 35:122–128. doi:10.1016/S0046-8177(03)00502-1
Balzar M, Winter MJ, de Boer CJ, Litvinov SV (1999) The biology of the 17-1A antigen (Ep-CAM). J Mol Med (Berl) 77:699–712
Stott SL et al (2010) Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med 2:25ra23
Stott S, Hsu C, Tsukrov D (2010) Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A 107:18392–18397
Dong Y et al (2013) Microfluidics and circulating tumor cells. J Mol Diagn 15:149–157
Hyun K-A, Jung H-I (2013) Microfluidic devices for the isolation of circulating rare cells: a focus on affinity-based, dielectrophoresis, and hydrophoresis. Electrophoresis 34:1028–1041
Li P, Stratton ZS, Dao M, Ritz J, Huang TJ (2013) Probing circulating tumor cells in microfluidics. Lab Chip 13:602–609
Stratton MR, Campbell PJ, Futreal PA (2009) The cancer genome. Nature 458:719–724
Park SY, Gönen M, Kim HJ, Michor F, Polyak K (2010) Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J Clin Invest 120:636–644
Torres L et al (2007) Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases. Breast Cancer Res Treat 102:143–155
Farabegoli F et al (2001) Clone heterogeneity in diploid and aneuploid breast carcinomas as detected by FISH. Cytometry 46:50–56
Jordan CT, Guzman ML, Noble M (2006) Cancer stem cells. N Engl J Med 355:1253–1261
Larzabal L et al (2013) Differential effects of drugs targeting cancer stem cell (CSC) and non-CSC populations on lung primary tumors and metastasis. PLoS One 8:e79798
Kuan W-C, Horák D, Plichta Z, Lee W-C (2014) Immunocapture of CD133-positive cells from human cancer cell lines by using monodisperse magnetic poly(glycidyl methacrylate) microspheres containing amino groups. Mater Sci Eng C Mater Biol Appl 34C:193–200
Ahmad A, Li Y, Bao B, Kong D, Sarkar FH (2013) Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals. Mol Nutr Food Res 58:79–86. doi:10.1002/mnfr.201300528
Nahi H, Sutlu T, Jansson M, Alici E, Gahrton G (2011) Clinical impact of chromosomal aberrations in multiple myeloma. J Intern Med 269:137–147
Neben K et al (2013) Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load. J Clin Oncol 31:4325–4332
Sawyer JR (2011) The prognostic significance of cytogenetics and molecular profiling in multiple myeloma. Cancer Genet 204:3–12
Wu S-M et al (2006) Quantum-dot-labeled DNA probes for fluorescence in situ hybridization (FISH) in the microorganism Escherichia coli. Chemphyschem 7:1062–1067
Iacobucci I, Lonetti A, Papayannidis C, Martinelli G (2013) Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia. Curr Cancer Drug Targets 13:791–810
Frumkin D et al (2008) Cell lineage analysis of a mouse tumor. Cancer Res 68:5924–5931
Navin N et al (2011) Tumour evolution inferred by single-cell sequencing. Nature 472:90–94
Alberts B et al (2007) Molecular biology of the cell, 5th edn. http://www.google.dk/books?hl=da&lr=&id=DjMmAgAAQBAJ&pgis=1
Tay S et al (2010) Single-cell NF-kappaB dynamics reveal digital activation and analogue information processing. Nature 466:267–271
Narsinh KH et al (2011) Brief report: Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. J Clin Invest 121:1217–1221
Diercks A, Kostner H, Ozinsky A (2009) Resolving cell population heterogeneity: real-time PCR for simultaneous multiplexed gene detection in multiple single-cell samples. PLoS One 4:e6326
Kantarjian HM et al (2009) Significance of increasing levels of minimal residual disease in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in complete cytogenetic response. J Clin Oncol 27:3659–3663
Graziano F et al (2011) Genetic activation of the MET pathway and prognosis of patients with high-risk, radically resected gastric cancer. J Clin Oncol 29:4789–4795
Hoshimoto S et al (2012) Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial. J Clin Oncol 30:3819–3826
Dalerba P et al (2011) Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat Biotechnol 29:1120–1127
Diehn M, Cho R, Lobo N, Kalisky T (2009) Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458:780–783
Spike BT et al (2012) A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer. Cell Stem Cell 10:183–197
Kikushige Y et al (2011) Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell 20:246–259
Lambolez B, Audinat E, Bochet P, Crépel F, Rossier J (1992) AMPA receptor subunits expressed by single Purkinje cells. Neuron 9:247–258
Bengtsson M, Ståhlberg A, Rorsman P, Kubista M (2005) Gene expression profiling in single cells from the pancreatic islets of Langerhans reveals lognormal distribution of mRNA levels. Genome Res 15:1388–1392
Tang F et al (2006) 220-plex microRNA expression profile of a single cell. Nat Protoc 1:1154–1159
Marcus JS, Anderson WF, Quake SR (2006) Microfluidic single-cell mRNA isolation and analysis. Anal Chem 78:3084–3089
Melin J, Quake SR (2007) Microfluidic large-scale integration: the evolution of design rules for biological automation. Annu Rev Biophys Biomol Struct 36:213–231
White AK et al (2011) High-throughput microfluidic single-cell RT-qPCR. Proc Natl Acad Sci U S A 108:13999–14004
Ramsköld D, Luo S, Wang Y, Li R (2012) Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat Biotechnol 30:777–782
Venter JC et al (2001) The sequence of the human genome. Science 291:1304–1351
Han J, Xiong J, Wang D, Fu X-D (2011) Pre-mRNA splicing: where and when in the nucleus. Trends Cell Biol 21:336–343
Hamada S, Masamune A, Shimosegawa T (2013) Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer. Front Physiol 4:331
Kümler I, Brünner N, Stenvang J, Balslev E, Nielsen DL (2013) A systematic review on topoisomerase 1 inhibition in the treatment of metastatic breast cancer. Breast Cancer Res Treat 138:347–358
Burden D, Osheroff N (1998) Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochim Biophys Acta 1400:139–154
Fortune J, Osheroff N (2000) Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. Prog Nucleic Acid Res Mol Biol 64:221–253
Poletto M et al (2012) Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers. Biochem Biophys Res Commun 424:34–39
Fosbrink M, Aye-Han N-N, Cheong R, Levchenko A, Zhang J (2010) Visualization of JNK activity dynamics with a genetically encoded fluorescent biosensor. Proc Natl Acad Sci U S A 107:5459–5464
Huang B et al (2007) Counting low-copy number proteins in a single cell. Science 315:81–84
Mellors JS, Jorabchi K, Smith LM, Ramsey JM (2010) Integrated microfluidic device for automated single cell analysis using electrophoretic separation and electrospray ionization mass spectrometry. Anal Chem 82:967–973
Shi Q et al (2012) Single-cell proteomic chip for profiling intracellular signaling pathways in single tumor cells. Proc Natl Acad Sci U S A 109:419–424
Sun J et al (2010) A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens. Cancer Res 70:6128–6138
Stougaard M, Juul S, Andersen FF, Knudsen BR (2011) Strategies for highly sensitive biomarker detection by Rolling Circle Amplification of signals from nucleic acid composed sensors. Integr Biol (Camb) 3:982–992
Perez-Hernandez D et al (2013) The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes. J Biol Chem 288:11649–11661
Varjosalo M et al (2013) Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. Nat Methods 10:307–314
Chen Y et al (2013) Bcl2-associated athanogene 3 interactome analysis reveals a new role in modulating proteasome activity. Mol Cell Proteomics 12:2804–2819
Davies CC, Chakraborty A, Diefenbacher ME, Skehel M, Behrens A (2013) Arginine methylation of the c-Jun coactivator RACO-1 is required for c-Jun/AP-1 activation. EMBO J 32:1556–1567
Juul S, Ho Y, Stougaard M (2011) Microfluidics-mediated isothermal detection of enzyme activity at the single molecule level. Conf Proc IEEE Eng Med Biol Soc 2011:3258–3261, http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=6090885
Andersen FF et al (2009) Multiplexed detection of site specific recombinase and DNA topoisomerase activities at the single molecule level. ACS Nano 3:4043–4054
Marcussen LB et al (2013) DNA-based sensor for real-time measurement of the enzymatic activity of human topoisomerase I. Sensors (Basel) 13:4017–4028
Kristoffersen EL, Givskov A, Jørgensen LA, Andersen AH, Stougaard M, Jensen PW. Ho Y-P, Knudsen BR “Topoisomerase II enzymatic activity detection using self-assembled small catenated DNA circles,” in preparation
Jensen PW et al (2013) Real-time detection of TDP1 activity using a fluorophore-quencher coupled DNA-biosensor. Biosens Bioelectron 48C:230–237
Jakobsen A-K, Stougaard M (2015) Combining a nanosensor and ELISA for measurement of Tyrosyl-DNA Phosphodiesterase 1 (TDP1) activity and protein amount in cell and tissue extract. Nano Life 05:1541001
Weltin A et al (2013) Cell culture monitoring for drug screening and cancer research: a transparent, microfluidic, multi-sensor microsystem. Lab Chip 14:138–146
Selck DA, Karymov MA, Sun B, Ismagilov RF (2013) Increased robustness of single-molecule counting with microfluidics, digital isothermal amplification, and a mobile phone versus real-time kinetic measurements. Anal Chem 85:11129–11136
Demello AJ (2006) Control and detection of chemical reactions in microfluidic systems. Nature 442:394–402
Van de Stolpe A, Pantel K, Sleijfer S, Terstappen LW, den Toonder JMJ (2011) Circulating tumor cell isolation and diagnostics: toward routine clinical use. Cancer Res 71:5955–5960
Smith DM, Simon JK, Baker JR (2013) Applications of nanotechnology for immunology. Nat Rev Immunol 13:592–605
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Controlled Release Society
About this chapter
Cite this chapter
Kristoffersen, E.L., Jepsen, M.L., Knudsen, B.R., Ho, YP. (2016). Microfluidics-based Single Cell Analytical Platforms for Characterization of Cancer. In: Howard, K., Vorup-Jensen, T., Peer, D. (eds) Nanomedicine. Advances in Delivery Science and Technology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3634-2_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3634-2_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-3632-8
Online ISBN: 978-1-4939-3634-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)